From 1 March 2026, Australian GPs will regain access to MBS item 11714, allowing claims for both ECG tracing and clinical interpretation. This major Medicare update reverses previous restrictions, restoring rebate parity for primary care diagnostics.
MBS Update: GP ECG Rebate Item 11714 Restored Read More »
Recent federal reforms mark a significant shift in Australian digital health governance with the introduction of a National Medicines Record (NMR). This guide explores how mandatory reporting will centralise prescribing data, mitigate risks from fragmented telehealth services, and enhance clinical oversight for General Practitioners.
The National Medicines Record: What the 2026 Reforms Mean for Australian GPs Read More »
The PBAC has recommended the PBS listing of semaglutide 2.4 mg for patients with established cardiovascular disease and severe obesity. This article outlines the specific eligibility criteria, including BMI thresholds and ethnicity adjustments, and examines the administrative implications for Australian general practice.
PBS Update: Semaglutide (Wegovy) Recommended for Cardiovascular Risk in Obesity Read More »
Quickly check whether an MBS item number is eligible for the 12.5% Medicare bulk billing practice incentive. Built for Australian general practice teams with links to official guidance.
Medicare Bulk Billing Eligible Services Item Checker Read More »
Navigating menopause in general practice presents unique challenges and opportunities. With new MBS items rolling out and a renewed focus on comprehensive, patient-centered care, GPs are better equipped to support women through this vital life stage. This article explores the evolving landscape of menopause assessment and management for Australian practitioners.
Navigating Menopause Care: New Women’s Health MBS Items Explained Read More »
From 1 July 2025, significant changes to the Medicare Benefits Schedule (MBS) chronic disease management framework will streamline how we manage patients with chronic conditions. Here’s your essential guide to what’s changing and how it affects your practice.
Major Changes Coming to Chronic Disease Management: What GPs Need to Know Read More »
In an era where 70% of Australian GPs express concern about their administrative workload—up from 60% just a year ago—finding practical ways to reduce this burden has never been more critical. As this administrative load continues to be cited as the primary reason GPs plan to leave practice within the next five years, implementing effective solutions is essential for both individual wellbeing and workforce sustainability.
Reclaiming Your Time: How Templates Can Boost Efficiency in Australian General Practice Read More »
The Australian Government has announced significant changes to the Medicare Benefits Schedule items for chronic disease management, with implementation now deferred until 1 July 2025. These changes represent the first major overhaul of the framework in almost two decades and aim to modernise and streamline chronic disease management in general practice.
Preparing for the New MBS Chronic Disease Management Framework: What GPs Need to Know Read More »
Bulk billing incentives are an essential component of the Medicare Benefits Schedule, designed to encourage practitioners to bulk bill eligible patients. Understanding the interaction between consultation item numbers, MyMedicare enrolment, and available incentives is crucial for both practice management and patient care.
Bulk Billing Incentives for GPs: The Impact of MyMedicare Read More »
The Australian healthcare landscape is constantly evolving, and recent changes to the Medicare Benefits Schedule (MBS) concerning bulk billing incentives are significant for General Practitioners. As of November 1st, 2023, we’ve seen an exciting development: increased Medicare bulk billing incentive payments, often referred to as “triple incentives,” for specific patient groups and consultation types.
